Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplant.

There are a limited number of studies that have evaluated the proteome of myelodysplastic syndrome (MDS) patients [1–9]. Two chemokines (CXCL-4 and CXCL-7) were found to be differentially depressed...